Advertisement
Visual dysfunction at baseline is associated with poor cognitive function among older U.S. adults

Visual Dysfunction Tied to Poor Cognitive Function in Seniors

0
Association identified using data from two nationally representative samples
The cost burden associated with vitiligo is high

Limited Economic Evidence for Vitiligo Treatments

0
Research reveals no evidence to support or refute value for money afforded by vitiligo treatments
There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy

Evolocumab Doesn’t Affect Cognition When Added to Statins

0
No significant between-group difference for patients receiving evolocumab or placebo added to statins
Coping support interventions can reduce anxiety and stress

Coping Support Assists Parents of Hospitalized Children

0
Meta-analysis: coping support interventions can reduce anxiety and stress, but not depression
Lifetime costs of care are substantially increased for individuals with dementia

Families Shoulder Majority of Costs Related to Dementia Care

0
Reducing functional decline or behavioral and psychological symptoms leads to lower lifetime costs
A sense of coherence is associated with cancer patients' acceptance of their illness

Perceived Social Support Lower for Cancer Caregivers Vs Patients

0
Greater support for caregivers may substantially strengthen the sense of coherence
Antidepressant use is common among U.S. individuals aged 12 years and older

Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.

0
Use is higher among females than males; long-term use for one-fourth of those taking antidepressants
Intraindividual variability of reaction time is independently associated with mortality

Intraindividual Variability in Reaction Time Tied to Mortality

0
Independent link identified, which changed very little after excluding incident dementia cases
Adoption of specialty access standards has not improved access to specialists

Specialist Access No Better With Adoption of Access Standards

0
No notable improvement in timely access to specialty services following implementation of standards
Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval

Studies Used for FDA Approval of Device Changes Often Low Quality

0
And, efficacy of drugs granted accelerated approval often confirmed only years after approval